| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $88.04M | $18.47M | $7.53M | $94.59M | $70.43M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $700.30M | $554.72M | $503.74M | $418.79M | $256.74M |
| R&D | $416.03M | $339.41M | $330.12M | $240.81M | $159.94M |
| SG&A | $284.27M | $215.31M | $173.61M | $177.98M | $96.80M |
| Operating Income | -$612.26M | -$536.25M | -$496.20M | -$324.20M | -$186.31M |
| Interest Expense | $45.58M | $37.70M | $28.31M | $19.41M | $16.44M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$784.96M | -$589.53M | -$526.24M | -$388.95M | -$215.31M |
| EPS (basic) | -6.5400 | -5.2600 | -5.4500 | -4.3300 | -2.8000 |
| EPS (diluted) | -6.5400 | -5.2600 | -5.4500 | -4.3300 | -2.8000 |
| Shares (diluted) | $120.10K | $111.98K | $96.52K | $89.83K | $76.89K |